GIA
HRMY icon

GHP Investment Advisors’s Harmony Biosciences HRMY Stock Holding History

GHP Investment Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73 Hold
2
– – ﹤0.01% 1315
2026
Q1 		$57 Buy
+2
New +$66 ﹤0.01% 1362

Other funds holding HRMY

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GHP Investment Advisors's HRMY Position: Q2 2026 in Review

GHP Investment Advisors held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 2 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

GHP Investment Advisors first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • GHP Investment Advisors held 2 shares of Harmony Biosciences worth $73 as of Q2 2026.
  • GHP Investment Advisors left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1315 holding.
  • GHP Investment Advisors first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.